ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,234.94
-1.03%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. uniQure NV (QURE)

  7. uniQure NV (QURE) Noticias

QURE uniQure NV

4.81
0.13 (2.78%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
uniQure NV QURE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.13 2.78% 4.81 17:41:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.78 4.66 4.965 4.69 4.68
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/3/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202407:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202407:00EDGAR2Form 8-K - Current report
28/2/202406:05GLOBEuniQure Announces 2023 Financial Results and Highlights..
26/2/202415:46EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202415:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202306:12EDGAR2Form 8-K - Current report
19/12/202306:05GLOBEuniQure Announces Update on Phase I/II Clinical Trials of..
11/12/202318:30PRNUSCSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb)..
08/12/202306:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
29/11/202306:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
17/11/202305:00EDGAR2Form 8-K - Current report
07/11/202306:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:31EDGAR2Form 8-K - Current report
07/11/202306:05GLOBEuniQure Announces Third Quarter 2023 Financial Results and..
27/10/202309:00PRNUSCSL and uniQure Win 2023 Prix Galien USA Award
26/10/202313:38PRNCASanté Canada autorise HEMGENIX® de CSL (étranacogène..
26/10/202313:14PRNCAHealth Canada Authorizes CSL's HEMGENIX® (etranacogene..
24/10/202306:05GLOBEuniQure Announces Major Presence at the European Society of..
06/10/202305:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202305:32EDGAR2Form DEF 14A - Other definitive proxy statements
05/10/202315:32EDGAR2Form 8-K - Current report
05/10/202306:05GLOBEuniQure Announces Strategic Reorganization to Reduce..
02/10/202320:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202306:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
20/9/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202312:59DJNRe/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit..
05/9/202306:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
01/9/202317:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
01/8/202315:30EDGAR2Form 8-K - Current report
01/8/202306:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202306:05GLOBEuniQure Announces Second Quarter 2023 Financial Results and..
12/7/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202309:58EDGAR2Form 144 - Report of proposed sale of securities
26/6/202306:11GLOBEuniQure Announces Leadership Addition to Support Advancement..
21/6/202306:05GLOBEuniQure Announces Update on U.S. Phase I/II Clinical Trial..
20/6/202306:05GLOBEuniQure announces achievement of $100 million..
20/6/202306:00PRNUSCSL Behring Announces the First Patient Has Received..
16/6/202306:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
15/5/202306:05GLOBEuniQure Announces Sale of Royalty Interest in HEMGENIX® for..
09/5/202306:05GLOBEuniQure Announces First Quarter 2023 Financial Results and..

Su Consulta Reciente

NASDAQ
QURE
uniQure NV
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados